期刊文献+

喉鳞状细胞癌组织中骨桥蛋白和p53的表达及其临床意义

Expressions and clinical significances of osteopontin and p53 in laryngeal squamous cell carcinoma tissues
原文传递
导出
摘要 目的研究人喉鳞状细胞癌(LSCC)及其癌旁相对正常组织中骨桥蛋白(OPN)和p53表达水平,并探讨两者的相互关系及其临床病理学意义。方法采用免疫组织化学SP法,对44例LSCC及癌旁组织手术切除标本常规制作石蜡包埋切片,检测OPN和p53的表达,结合喉癌患者的临床病理学特征进行分析。结果①44例喉癌组织中OPN和p53表达阳性率分别为75.0%(33例)和65.9%(29例),癌旁相对正常组织中分别为13.6%(6例)和2.3%(1例);②OPN的表达与颈部淋巴结转移、临床分期、病理组织学分级有关,与性别、年龄、原发部位无相关性;③OPN和p53的表达呈显著正相关(r=0.360,P=0.016)。结论 OPN在喉癌组织中的表达高于癌旁相对正常组织,可能参与了喉癌的发生、发展和转移,有可能成为判断预后的重要生物学标记物。 Objective To study OPN and p53 expressions and detect their correlation and clinicopathological value in laryngeal squamous cell carcinoma (LSCC) and adjacent tissues. Methods The SP immunohistochemical method was used to study the OPN and p53 expressions in routinely embedded sections of surgical specimens of 44 laryngeal squamous cell carcinomas and adjacent tissues, and clinicopathological features were analyzed. Results (1)The positive rates of OPN and p53 protein were 75.0 % (33 cases)and 65.9% (29 cases) in LSCC, and 13.6% (6 cases) and 2.3% ( 1 case) in adjacent tissue respectively; (2)The OPN expression level was significantly correlated with tumor stage, grade and the presence of lymph nodes, but was not correlated with age, gender and primary tumor site; (~)Expression of OPN was positively correlated with that of p53 ( r = 0. 360, P = 0. 016 ). Conclusions OPN expression is higher in LSCC than in adjacent tissue, and may participate in the development and metastasis of LSCC. OPN might be an important biological marker in LSCC prognosis.
出处 《山东大学耳鼻喉眼学报》 CAS 2011年第2期19-22,共4页 Journal of Otolaryngology and Ophthalmology of Shandong University
关键词 喉肿瘤 鳞状细胞 骨桥蛋白 P53 Laryngeal neoplasms Carcinoma, squamous cell Osteopontin p53
  • 相关文献

参考文献16

  • 1Shevde L A, Das S, Clark D W, et al. Osteopontin: an effector and an effect of tumor metastasis [ J ]. Curr Mol Med, 2010, 10(1) :71-81.
  • 2Wai P Y, Kuo P C. The role of osteopontin in tumor metastasis[J].J Surg Res, 2004, 121(2) :228- 241.
  • 3Briese J, Cheng S, Ezzat S, et al. Osteopontin (OPN) expression in thyroid carcinoma E J ]. Anticancer Res, 2010, 30(5) :1681-1688.
  • 4Chen R X, Xia Y H, Cui J F, et al. Osteopontin, a single marker for predicting the prognosis of patients with tumor-node-metastasis stage I hepatocellular carcinoma after surgical resection[ J]. J Gastroenterol Hepatol, 2010, 25(8) :1435-1442.
  • 5Cui R, Takahashi F, Ohashi R, et al. Osteopontin is involved in the formation of malignant pleural effusion in lung cancer[J].Lung Cancer, 2009, 63(3) : 368-374.
  • 6Celetti A, Testa D, Staibano S, et al. Overexpression of the cytokine osteoponfin identifies aggressive laryngeal sqnamous cell carcinomas and enhances carcioma cell proliferation and invasiveness [J]. Clin Cancer Res, 2005, 11 (22) :8019-8027.
  • 7Wang X, Chao L, Ma G, et al. Primary breast carcinoma: association of mammographic calcifications with osteopontin expression [ J ]. Radiology, 2010,254 ( 1 ) : 69 -78.
  • 8Lane D P. The role of mutant p53 in human cancer[J].J Pathol, 2011, 223(2) :116-126.
  • 9Eto M, Kodama S, Nomi N, et al. Clinical significance of elevated osteopontin levels in head and neck cancer patients[J~. Auris Nasus Larynx, 2007, 34(3) :343-346.
  • 10Dai J, Li B, Shi J, et al. A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo[J]. Cancer Immunol Immunother, 2010, 59 (3) : 355 -366.

二级参考文献9

  • 1秦兆冰,董明敏,万保罗,刘政国,吴凯彦,银平章.p53蛋白在喉鳞癌及癌旁组织中表达的研究[J].临床耳鼻咽喉科杂志,1996,10(3):134-136. 被引量:5
  • 2Lane D P. On the expression of the p53 protein in human cancer. Mol Biol Rep, 1994,19: 23 - 29.
  • 3Levine A J. The p53 tumour suppressor gene and product. Cancer Surv, 1992,12 : 59 - 79.
  • 4Singh B, Reddy P G, Goberdhan A, et al. p53 regulates cell survival by intibiting PIK3CA in squamous cell carcinomas. Genes Dev,2002,16: 984- 993.
  • 5Gale N, kambic V, Poljak M, et al. Chromosomes 7,17 polysomies and overexpression of epidermal growth factor receptor and p53 protein in epithelial hyperplastic laryngeal leaions. Oncology, 2000,58:117- 125.
  • 6Nadal A, Campo E,Pinto J,et al. p53 expression in normal, dysplastic and neoplastic laryngeal epithelium.Absence of a correlation with prognostic factors. J Pathol, 1995,175:181- 188.
  • 7Garozzo A, Cutrona D, Palmeri S, et al. The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma. Acta Otorhinolaryngol Ital,1999,19: 342-347.
  • 8Dolcetti R, Doglioni C, Maestro R, et al. p53 over-expression is an early event in the development of human squamous cell carcinoma of the larynx: genetic and prognostic implications. Int J Cancer, 1992, 52: 178-182.
  • 9Kazkayasi M,Hucumenoglu S, Siriner G I,et al. Overexpression of p53 and c-erbB-2 oncoproteins in laryngeal carcinoma. Eur Arch Otorhinolaryngol, 2001,258:329-335.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部